🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Antiviral resistance remains an important issue for long-term NA therapy. F...
Status
Completed
Location
Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2014-05-12
Trial ID
NCT02019966
Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Status
Recruiting
Location
General Hospital of Northern Theater Command
Start Date
2024-07-02
Trial ID
NCT06216821
Treatments Being Tested
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This was an open-label, non-randomized Phase 1/2 safety study of INCAGN0187...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2016-06-20
Trial ID
NCT02697591
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
In patients naive to treatment or after a 2-week washout period for patient...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00890591
Treatments Being Tested
This study will help researchers collect more information about how effecti...
Status
Active Not Recruiting
Location
Stanford University Medical Center (Data collection only)
Start Date
2020-12-03
Trial ID
NCT04447768
Treatments Being Tested
This study is being done to learn more about a new medicine called PF-08634...
Status
Recruiting
Location
Clearview Cancer Institute (Crestwood)
Start Date
2026-06-30
Trial ID
NCT07489066
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested